Vipul Sheth

452 total citations
22 papers, 273 citations indexed

About

Vipul Sheth is a scholar working on Hematology, Oncology and Surgery. According to data from OpenAlex, Vipul Sheth has authored 22 papers receiving a total of 273 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 10 papers in Oncology and 5 papers in Surgery. Recurrent topics in Vipul Sheth's work include Hematopoietic Stem Cell Transplantation (11 papers), Acute Myeloid Leukemia Research (8 papers) and CAR-T cell therapy research (5 papers). Vipul Sheth is often cited by papers focused on Hematopoietic Stem Cell Transplantation (11 papers), Acute Myeloid Leukemia Research (8 papers) and CAR-T cell therapy research (5 papers). Vipul Sheth collaborates with scholars based in United States, India and United Kingdom. Vipul Sheth's co-authors include Jordan Gauthier, Marie Bleakley, Melinda A. Biernacki, Corinne Summers, Bhawna Sirohi, Shailesh V. Shrikhande, Ghulam Mufti, Mukta Ramadwar, Arnon Nagler and Jiřı́ Mayer and has published in prestigious journals such as Journal of Clinical Oncology, The American Journal of Gastroenterology and Frontiers in Oncology.

In The Last Decade

Vipul Sheth

20 papers receiving 269 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vipul Sheth United States 7 184 99 84 58 50 22 273
Eugenio Galli Italy 9 176 1.0× 46 0.5× 49 0.6× 37 0.6× 50 1.0× 43 280
Alessandro Crotta United States 7 273 1.5× 99 1.0× 55 0.7× 48 0.8× 43 0.9× 26 369
Rebecca Epperly United States 7 171 0.9× 40 0.4× 72 0.9× 83 1.4× 59 1.2× 30 241
Kyogo Suzuki Japan 6 185 1.0× 69 0.7× 80 1.0× 167 2.9× 44 0.9× 15 333
Sanbin Wang China 9 137 0.7× 102 1.0× 52 0.6× 74 1.3× 27 0.5× 31 259
Minh Tran United States 6 141 0.8× 35 0.4× 69 0.8× 80 1.4× 36 0.7× 13 259
David M. Cordas dos Santos Germany 8 251 1.4× 49 0.5× 45 0.5× 82 1.4× 34 0.7× 16 304
Elizabeth Budde United States 9 161 0.9× 88 0.9× 48 0.6× 105 1.8× 28 0.6× 26 275
Bryan Do United States 6 187 1.0× 32 0.3× 53 0.6× 49 0.8× 37 0.7× 7 288

Countries citing papers authored by Vipul Sheth

Since Specialization
Citations

This map shows the geographic impact of Vipul Sheth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vipul Sheth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vipul Sheth more than expected).

Fields of papers citing papers by Vipul Sheth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vipul Sheth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vipul Sheth. The network helps show where Vipul Sheth may publish in the future.

Co-authorship network of co-authors of Vipul Sheth

This figure shows the co-authorship network connecting the top 25 collaborators of Vipul Sheth. A scholar is included among the top collaborators of Vipul Sheth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vipul Sheth. Vipul Sheth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Singh, Reema, et al.. (2025). ABCL-454: Real-World Experience of Glofitamab in Refractory Lymphomas: A Compassionate-Use Program Experience. Clinical Lymphoma Myeloma & Leukemia. 25. S737–S738.
2.
Singh, Reema, et al.. (2024). Real World Outcome of High-Risk Multiple Myeloma: An Indian Tertiary Care Centre Experience. Clinical Lymphoma Myeloma & Leukemia. 25(2). e110–e119.
3.
Sheth, Vipul, Victoria Potter, Hugues de Lavallade, et al.. (2021). Mixed T cell lineage chimerism in acute leukemia/MDS using pre-emptive donor lymphocyte infusion strategy—Is it prognostic?—a single-center retrospective study. Blood Cancer Journal. 11(7). 5 indexed citations
4.
Sheth, Vipul, et al.. (2021). S534 Sarcopenia Is a Risk Factor for Pelvic Organ Prolapse Independent of Age. The American Journal of Gastroenterology. 116(1). S243–S243. 1 indexed citations
5.
6.
Sheth, Vipul & Jordan Gauthier. (2020). Taming the beast: CRS and ICANS after CAR T-cell therapy for ALL. Bone Marrow Transplantation. 56(3). 552–566. 153 indexed citations
7.
Biernacki, Melinda A., Vipul Sheth, & Marie Bleakley. (2020). T cell optimization for graft-versus-leukemia responses. JCI Insight. 5(9). 26 indexed citations
8.
Summers, Corinne, Vipul Sheth, & Marie Bleakley. (2020). Minor Histocompatibility Antigen-Specific T Cells. Frontiers in Pediatrics. 8. 284–284. 20 indexed citations
9.
Sheth, Vipul, et al.. (2020). Preemptive and Upfront Plerixafor: Safe and Effective Strategy for Patients Undergoing Autologous Stem Cell transplant and at High Risk for Mobilization Failure. Indian Journal of Medical and Paediatric Oncology. 41(1). 19–22. 1 indexed citations
10.
11.
Sheth, Vipul, Victoria Potter, Shreyans Gandhi, et al.. (2019). Similar outcomes of alemtuzumab-based hematopoietic cell transplantation for SAA patients older or younger than 50 years. Blood Advances. 3(20). 3070–3079. 10 indexed citations
12.
Sheth, Vipul, Myriam Labopin, Jonathan Canaani, et al.. (2018). Comparison of FLAMSA-based reduced intensity conditioning with treosulfan/fludarabine conditioning for patients with acute myeloid leukemia: an ALWP/EBMT analysis. Bone Marrow Transplantation. 54(4). 531–539. 15 indexed citations
13.
Sheth, Vipul, et al.. (2018). Pegfilgrastim: More Cost Effective and Equally Efficacious Option as Compared to Filgrastim in Autologous Stem Cell Transplant. Indian Journal of Hematology and Blood Transfusion. 35(1). 66–71. 3 indexed citations
14.
Sheth, Vipul, Sigal Grisariu, Batia Avni, et al.. (2018). Fludarabine‐based reduced toxicity yet myeloablative conditioning is effective and safe particularly in patients with high‐risk thalassemia undergoing allogeneic transplantation. Pediatric Blood & Cancer. 65(11). e27312–e27312. 1 indexed citations
15.
Sheth, Vipul, Boaz Nachmias, Sigal Grisariu, et al.. (2018). Augmented myeloablative conditioning with thiotepa in acute myeloid leukemia – improved outcomes with similar toxicity. Leukemia & lymphoma. 60(3). 726–733. 2 indexed citations
16.
Sheth, Vipul, et al.. (2017). Engraftment Syndrome: Clinical Features and Predictive Factors in Autologous Stem Cell Transplant. Indian Journal of Hematology and Blood Transfusion. 34(3). 448–453. 11 indexed citations
17.
Shapira, Michal, Vipul Sheth, Sigal Grisariu, et al.. (2017). Regional intra-arterial steroid treatment in 120 patients with steroid-resistant or -dependent GvHD. Bone Marrow Transplantation. 52(10). 1416–1422. 4 indexed citations
18.
Sheth, Vipul, et al.. (2015). Efficacy of plerixafor with GCSF for mobilization of PBSC: A single center experience.. Journal of Clinical Oncology. 33(15_suppl). e18011–e18011. 1 indexed citations
19.
20.
Sirohi, Bhawna, et al.. (2014). Neoadjuvant therapy in Indian patients with locally advanced gall bladder cancer: Tata Memorial Centre (TMC) experience.. Journal of Clinical Oncology. 32(3_suppl). 379–379. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eugenio Galli Breakdown of academic impact, for papers by Alessandro Crotta Breakdown of academic impact, for papers by Rebecca Epperly Breakdown of academic impact, for papers by Kyogo Suzuki Breakdown of academic impact, for papers by Sanbin Wang Breakdown of academic impact, for papers by Minh Tran Breakdown of academic impact, for papers by David M. Cordas dos Santos Breakdown of academic impact, for papers by Elizabeth Budde Breakdown of academic impact, for papers by Bryan Do
Rankless by CCL
2026